Immunotherapy successfully fights leukemia in relapsed patient

07/11/2013 |

A relapsed leukemia patient taking part in the cellular immunotherapy Phase I cancer trial at Seattle Children's Hospital was deemed free of leukemia cells after about seven months of treatment. The trial is testing the effectiveness of modifying the function of T-cells from the patient's own blood so that they attack the cancer cells. Findings showed that the patient "has had a positive response to the T-cell therapy and, at this time, we do not detect any leukemia cells," lead investigator Dr. Rebecca Gardner said.

View Full Article in:

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT